Literature DB >> 15937499

Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma.

G G Wulf, J Hasenkamp, W Jung, B Chapuy, L Truemper, B Glass.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15937499     DOI： 10.1038/sj.bmt.1705036

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

Review 1.  Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma.

Authors:  Koen van Besien
Journal:  Curr Opin Oncol       Date:  2011-11       Impact factor: 3.645

Review 2.  Hemopoietic stem cell transplantation in T-cell malignancies: who, when, and how?

Authors:  Francesco d'Amore; Esa Jantunen; Thomas Relander
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

3.  Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.

Authors:  Peter Reimer
Journal:  Adv Hematol       Date:  2010-12-21

4.  Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas.

Authors:  M Delioukina; J Zain; J M Palmer; N Tsai; S Thomas; S Forman
Journal:  Bone Marrow Transplant       Date:  2011-02-28       Impact factor: 5.483

Review 5.  Management of advanced-stage peripheral T-cell lymphomas.

Authors:  Eva Kimby
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 4.213

Review 6.  New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.

Authors:  Peter Reimer
Journal:  Cancer Manag Res       Date:  2015-06-03       Impact factor: 3.989

7.  How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?

Authors:  H-N Lin; C-Y Liu; J-T Pai; F-P Chang; C-F Yang; Y-B Yu; L-T Hsiao; T-J Chiou; J-H Liu; J-P Gau; C-H Tzeng; P-M Chen; Y-C Hong
Journal:  Blood Cancer J       Date:  2012-10-12       Impact factor: 11.037

8.  Comparison of Allogeneic Stem Cell Transplant and Autologous Stem Cell Transplant in Refractory or Relapsed Peripheral T-Cell Lymphoma: A Systematic Review and Meta-analysis.

Authors:  Jun Du; Dandan Yu; Xinle Han; Lijun Zhu; Zoufang Huang
Journal:  JAMA Netw Open       Date:  2021-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.